Beutler E, Gelbart T, West C
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Blood Cells Mol Dis. 2001 Jul-Aug;27(4):728-30. doi: 10.1006/bcmd.2001.0441.
The Toll (Tlr) receptors facilitate innate immunity by detecting products that are unique to invading microorganisms. Stimulation of these receptors can produce severe reactions and death. We propose that synergy between receptors for different microbial products would provide a safety mechanism, preventing inappropriate, potentially fatal reactions by reacting to low concentrations of ligands when more than a single ligand is present.
Striking synergy is noted between the ligand for Tlr4, lipopolysaccharide (LPS), and a ligand for Tlr2, muramyl dipeptide (MDP), in the release of tumor necrosis factor from RAW cells.
Synergy between a ligand for Tlr2 and Tlr4 can be demonstrated in a simple in vitro system. The greater sensitivity of MDP-stimulated cells to LPS may explain the data that were once interpreted incorrectly as indicating that Tlr2 is the endotoxin receptor.
Toll(Tlr)受体通过检测入侵微生物特有的产物来促进先天免疫。这些受体的刺激可产生严重反应甚至死亡。我们提出,不同微生物产物受体之间的协同作用将提供一种安全机制,当存在多种配体时,通过对低浓度配体做出反应来防止不适当的、潜在致命的反应。
在RAW细胞释放肿瘤坏死因子的过程中,Tlr4的配体脂多糖(LPS)和Tlr2的配体胞壁酰二肽(MDP)之间存在显著的协同作用。
Tlr2和Tlr4的配体之间的协同作用可以在一个简单的体外系统中得到证明。MDP刺激的细胞对LPS的更高敏感性可能解释了曾经被错误解释为表明Tlr2是内毒素受体的数据。